Clinical Trial Update: A Study With Tarceva and Chemotherapy vs. Chemotherapy Alone in Patients With Advanced Lung Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial update evaluating Tarceva (erlotinib) in combination with chemotherapy versus chemotherapy alone in patients with advanced lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Drugs mentioned

• Chemotherapy (chemotherapy)
• Tarceva (erlotinib)

Snippet

Sponsor: Genentech, Inc. | Conditions: Lung Cancer | Phase 3 | Status: COMPLETED